138 related articles for article (PubMed ID: 31941608)
1. Transgelin-2 contributes to proliferation and progression of hepatocellular carcinoma via regulating Annexin A2.
Shi J; Ren M; She X; Zhang Z; Zhao Y; Han Y; Lu D; Lyu L
Biochem Biophys Res Commun; 2020 Mar; 523(3):632-638. PubMed ID: 31941608
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma.
Zhang H; Yao M; Wu W; Qiu L; Sai W; Yang J; Zheng W; Huang J; Yao D
Tumour Biol; 2015 Dec; 36(12):9373-83. PubMed ID: 26109000
[TBL] [Abstract][Full Text] [Related]
3. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.
Mohammad HS; Kurokohchi K; Yoneyama H; Tokuda M; Morishita A; Jian G; Shi L; Murota M; Tani J; Kato K; Miyoshi H; Deguchi A; Himoto T; Usuki H; Wakabayashi H; Izuishi K; Suzuki Y; Iwama H; Deguchi K; Uchida N; Sabet EA; Arafa UA; Hassan AT; El-Sayed AA; Masaki T
Int J Oncol; 2008 Dec; 33(6):1157-63. PubMed ID: 19020748
[TBL] [Abstract][Full Text] [Related]
4. Pseudogene Annexin A2 Pseudogene 1 Contributes to Hepatocellular Carcinoma Progression by Modulating Its Parental Gene ANXA2 via miRNA-376a-3p.
Ou H; Liu Q; Lin J; He W; Zhang W; Ma J; Wang W
Dig Dis Sci; 2021 Nov; 66(11):3903-3915. PubMed ID: 33398718
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA LUCAT1 promotes tumourigenesis by inhibiting ANXA2 phosphorylation in hepatocellular carcinoma.
Lou Y; Yu Y; Xu X; Zhou S; Shen H; Fan T; Wu D; Yin J; Li G
J Cell Mol Med; 2019 Mar; 23(3):1873-1884. PubMed ID: 30588744
[TBL] [Abstract][Full Text] [Related]
6. High Expression of
Wang QS; Shi LL; Sun F; Zhang YF; Chen RW; Yang SL; Hu JL
Dis Markers; 2019; 2019():9267046. PubMed ID: 30881525
[TBL] [Abstract][Full Text] [Related]
7. Annexin A2 promotion of hepatocellular carcinoma tumorigenesis
Qiu LW; Liu YF; Cao XQ; Wang Y; Cui XH; Ye X; Huang SW; Xie HJ; Zhang HJ
World J Gastroenterol; 2020 May; 26(18):2126-2137. PubMed ID: 32476780
[TBL] [Abstract][Full Text] [Related]
8. Annexin A2 promotes the migration and invasion of human hepatocellular carcinoma cells in vitro by regulating the shedding of CD147-harboring microvesicles from tumor cells.
Zhang W; Zhao P; Xu XL; Cai L; Song ZS; Cao DY; Tao KS; Zhou WP; Chen ZN; Dou KF
PLoS One; 2013; 8(8):e67268. PubMed ID: 23950866
[TBL] [Abstract][Full Text] [Related]
9. ANXA2 enhances the progression of hepatocellular carcinoma via remodeling the cell motility associated structures.
Shi H; Xiao L; Duan W; He H; Ma L; Da M; Duan Y; Wang Q; Wu H; Song X; Hou Y
Micron; 2016 Jun; 85():26-33. PubMed ID: 27060670
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.
Zhang J; Cheng J; Zeng Z; Wang Y; Li X; Xie Q; Jia J; Yan Y; Guo Z; Gao J; Yao M; Chen X; Lu F
Oncotarget; 2015 Dec; 6(39):42040-52. PubMed ID: 26547929
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA FOXD2-AS1 plays an oncogenic role in hepatocellular carcinoma by targeting miR‑206.
Chang Y; Zhang J; Zhou C; Qiu G; Wang G; Wang S; Chang X; Li X; Fan L
Oncol Rep; 2018 Dec; 40(6):3625-3634. PubMed ID: 30272362
[TBL] [Abstract][Full Text] [Related]
12. TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.
Han MZ; Xu R; Xu YY; Zhang X; Ni SL; Huang B; Chen AJ; Wei YZ; Wang S; Li WJ; Zhang Q; Li G; Li XG; Wang J
J Exp Clin Cancer Res; 2017 Nov; 36(1):155. PubMed ID: 29110682
[TBL] [Abstract][Full Text] [Related]
13. TAGLN2, a novel regulator involved in Hepatitis B virus transcription and replication.
Yu Y; He Z; Cao Y; Tang H; Huang F
Biochem Biophys Res Commun; 2016 Sep; 477(4):1051-1058. PubMed ID: 27402267
[TBL] [Abstract][Full Text] [Related]
14. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
15. Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration.
Gao HJ; Zhao MC; Zhang YJ; Zhou DS; Xu L; Li GB; Chen MS; Liu J
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1151-62. PubMed ID: 25446815
[TBL] [Abstract][Full Text] [Related]
16. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.
Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J
Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092
[TBL] [Abstract][Full Text] [Related]
17. UBAP2 negatively regulates the invasion of hepatocellular carcinoma cell by ubiquitinating and degradating Annexin A2.
Bai DS; Wu C; Yang LX; Zhang C; Zhang PF; He YZ; Cai JB; Song ZJ; Dong ZR; Huang XY; Ke AW; Shi GM
Oncotarget; 2016 May; 7(22):32946-55. PubMed ID: 27121050
[TBL] [Abstract][Full Text] [Related]
18. A novel interplay between oncogenic PFTK1 protein kinase and tumor suppressor TAGLN2 in the control of liver cancer cell motility.
Leung WK; Ching AK; Chan AW; Poon TC; Mian H; Wong AS; To KF; Wong N
Oncogene; 2011 Nov; 30(44):4464-75. PubMed ID: 21577206
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of transgelin 2 promotes breast cancer metastasis by activating the reactive oxygen species/nuclear factor‑κB signaling pathway.
Yang L; Hong Q; Xu SG; Kuang XY; Di GH; Liu GY; Wu J; Shao ZM; Yu SJ
Mol Med Rep; 2019 Nov; 20(5):4045-4258. PubMed ID: 31485630
[TBL] [Abstract][Full Text] [Related]
20. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
